相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study
Aurelie Lenglet et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis
Steven Habbous et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Long-Term Evaluation of Colestilan in Chronic Kidney Disease Stage 5 Dialysis Patients with Hyperphosphataemia
Francesco Locatelli et al.
BLOOD PURIFICATION (2016)
Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials
Leena Patel et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Ergocalciferol Supplementation in Hemodialysis Patients With Vitamin D Deficiency: A Randomized Clinical Trial
Dana C. Miskulin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis
Stuart M. Sprague et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Use of 2MD, a Novel Oral Calcitriol Analog, in Hemodialysis Patients with Secondary Hyperparathyroidism
Richa Pandey et al.
AMERICAN JOURNAL OF NEPHROLOGY (2016)
Rates and Outcomes of Parathyroidectomy for Secondary Hyperparathyroidism in the United States
Sun Moon Kim et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Effect of cholecalciferol on vitamin D-regulatory proteins in monocytes and on inflammatory markers in dialysis patients: A randomized controlled trial
Marion Schneider Meireles et al.
CLINICAL NUTRITION (2016)
Comparison between paricalcitol and active non-selective vitamin D receptor activator for secondary hyperparathyroidism in chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Panpan Cai et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2016)
Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease
Natalia Carrillo-Lopez et al.
KIDNEY INTERNATIONAL (2016)
Subtotal parathyroidectomy for secondary renal hyperparathyroidism: a 20-year surgical outcome study
Aleksander Konturek et al.
LANGENBECKS ARCHIVES OF SURGERY (2016)
Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis
Nigar Sekercioglu et al.
PLOS ONE (2016)
Factors predictive of critical value of hypocalcemia after total parathyroidectomy without autotransplantation in patients with secondary hyperparathyroidism
Meng Yang et al.
RENAL FAILURE (2016)
Long-term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis
Lin Chen et al.
RENAL FAILURE (2016)
Impact of Lanthanum Carbonate on Prognosis of Chronic Hemodialysis Patients: A Retrospective Cohort Study (Kawashima Study)
Kenji Tsuchida et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2016)
Comparison of the Pharmacological Effects of Paricalcitol Versus Calcitriol on Secondary Hyperparathyroidism in the Dialysis Population
Zeljka Veceric-Haler et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2016)
Effect of Paricalcitol on FGF-23 and Klotho in Kidney Transplant Recipients
Javier Donate-Correa et al.
TRANSPLANTATION (2016)
Diagnostic Accuracy Study of Intraoperative and Perioperative Serum Intact PTH Level for Successful Parathyroidectomy in 501 Secondary Hyperparathyroidism Patients
Lina Zhang et al.
SCIENTIFIC REPORTS (2016)
Procaine Inhibits Osteo/Odontogenesis through Wnt/β-Catenin Inactivation
Carmen Herencia et al.
PLOS ONE (2016)
Association of Increased Serum Leptin with Ameliorated Anemia and Malnutrition in Stage 5 Chronic Kidney Disease Patients after Parathyroidectomy
Yao Jiang et al.
SCIENTIFIC REPORTS (2016)
The fibroblast growth factor receptor mediates the increased FGF23 expression in acute and chronic uremia
Alia Hassan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5
Geoffrey A. Block et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Comparison of Fracture Risk Prediction among Individuals with Reduced and Normal Kidney Function
Kyla L. Naylor et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial
Patrick S. Parfrey et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients
Gregory Bell et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
Parathyroid-specific deletion of dicer-dependent microRNAs abrogates the response of the parathyroid to acute and chronic hypocalcemia and uremia
Vitali Shilo et al.
FASEB JOURNAL (2015)
Efficacy of calcitriol compared to alfacalcidol for the treatment of secondary hyperparathyroidism in peritoneal dialysis patients
Sarah Bezzaoucha et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2015)
Bone Mineral Density Predicts Fractures in Chronic Kidney Disease
Sarah L. West et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
The Effect of Various Boiling Conditions on Reduction of Phosphorus and Protein in Meat
Sakiko Ando et al.
JOURNAL OF RENAL NUTRITION (2015)
Restoration of Parathyroid Function After Change of Phosphate Binder From Calcium Carbonate to Lanthanum Carbonate in Hemodialysis Patients With Suppressed Serum Parathyroid Hormone
Masaaki Inaba et al.
JOURNAL OF RENAL NUTRITION (2015)
Impact of Phosphorus Restriction and Vitamin D-Substitution on Secondary Hyperparathyroidism in a Proteinuric Mouse Model
Bernhard N. Bohnert et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2015)
Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism
Francisco Jose Borrego Utiel et al.
NEFROLOGIA (2015)
Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement
David Goldsmith et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study
Jose Luis Fernandez-Martin et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
The Use of Calcimimetics for the Treatment of Secondary Hyperparathyroidism: A 10 Year Evidence Review
Mariano Rodriguez et al.
SEMINARS IN DIALYSIS (2015)
Effects of a Single, High Oral Dose of 25-Hydroxycholecalciferol on the Mineral Metabolism Markers in Hemodialysis Patients
Jose Luis Merino et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2015)
Efficacy and safety of body weight-adapted oral cholecalciferol substitution in dialysis patients with vitamin D deficiency
Emanuel Zitt et al.
BMC NEPHROLOGY (2015)
Effect of VDRA on survival in incident hemodialysis patients: results of the FARO-2 observational study
Piergiorgio Messa et al.
BMC NEPHROLOGY (2015)
Low Magnesium Levels and FGF-23 Dysregulation Predict Mitral Valve Calcification as well as Intima Media Thickness in Predialysis Diabetic Patients
Ana Paula Silva et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2015)
Long-Term Clinical Practice Experience with Cinacalcet for Treatment of Hypercalcemic Hyperparathyroidism after Kidney Transplantation
Ursula Thiem et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Effects of phosphorus-restricted diet and phosphate-binding therapy on outcomes in patients with chronic kidney disease
Domenico Russo et al.
JOURNAL OF NEPHROLOGY (2015)
Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial
Sharon M. Moe et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Ferric Citrate Controls Phosphorus and Delivers Iron in Patients on Dialysis
Julia B. Lewis et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Survival advantage of lanthanum carbonate for hemodialysis patients with uncontrolled hyperphosphatemia
Hirotaka Komaba et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice
Maria Vittoria Arcidiacono et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Ergocalciferol versus Cholecalciferol for Nutritional Vitamin D Replacement in CKD
Roberto Mangoo-Karim et al.
NEPHRON (2015)
Vitamin D status and cholecalciferol supplementation in chronic kidney disease patients: an Italian cohort report
Adamasco Cupisti et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE (2015)
Novel, Selective Vitamin D Analog Suppresses Parathyroid Hormone in Uremic Animals and Postmenopausal Women
Julia B. Zella et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
Lower Serum Magnesium Is Associated with Cardiovascular Risk Factors and Mortality in Haemodialysis Patients
Patrcia Joao Matias et al.
BLOOD PURIFICATION (2014)
A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients
Juergen Floege et al.
KIDNEY INTERNATIONAL (2014)
AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patients
Kevin J. Martin et al.
KIDNEY INTERNATIONAL (2014)
Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: a multicentre, retrospective, 3-year study
Jose-Vicente Torregrosa et al.
NEPHROLOGY (2014)
Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects
Kevin J. Martin et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Magnesium modulates parathyroid hormone secretion and upregulates parathyroid receptor expression at moderately low calcium concentration
Maria E. Rodriguez-Ortiz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Comparison of AMG 416 and cinacalcet in rodent models of uremia
Sarah Walter et al.
BMC NEPHROLOGY (2014)
Sevelamer Versus Calcium Carbonate in Incident Hemodialysis Patients: Results of an Open-Label 24-Month Randomized Clinical Trial
Biagio Di Iorio et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Vitamin D Treatment and Mortality in Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Flore Duranton et al.
AMERICAN JOURNAL OF NEPHROLOGY (2013)
Oral Paricalcitol Reduces the Prevalence of Posttransplant Hyperparathyroidism: Results of an Open Label Randomized Trial
H. Amer et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Relation Between Circulating Levels of 25(OH) Vitamin D and Parathyroid Hormone in Chronic Kidney Disease: Quest for a Threshold
Marie Metzger et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
The Clinical Course of Treated Hyperparathyroidism Among Patients Receiving Hemodialysis and the Effect of Cinacalcet: The EVOLVE Trial
Patrick S. Parfrey et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis
Sophie A. Jamal et al.
LANCET (2013)
Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study
Daniel W. Coyne et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Evaluation of colestilan in chronic kidney disease dialysis patients with hyperphosphataemia and dyslipidaemia: a randomized, placebo-controlled, multiple fixed-dose trial
Francesco Locatelli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Comparison between a second and a third generation parathyroid hormone assay in hemodialysis patients
Marie-Helene Gannage-Yared et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Cinacalcet in Patients with Chronic Kidney Disease: A Cumulative Meta-Analysis of Randomized Controlled Trials
Suetonia C. Palmer et al.
PLOS MEDICINE (2013)
Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
Sarah Walter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Effects of sevelamer hydrochloride on mortality, lipid abnormality and arterial stiffness in hemodialyzed patients: a propensity-matched observational study
Soichiro Iimori et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2012)
Mortality in Kidney Disease Patients Treated with Phosphate Binders: A Randomized Study
Biagio Di Iorio et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Bone Mineral Density and Fracture Risk in Older Individuals with CKD
Robert H. Yenchek et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Update on Wnt signaling in bone cell biology and bone disease
David G. Monroe et al.
GENE (2012)
Calcium Deficiency Reduces Circulating Levels of FGF23
Maria E. Rodriguez-Ortiz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Parathyroidectomy for the attainment of NKF-K/DOQI™ and KDIGO recommended values for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism
Bojan Kovacevic et al.
LANGENBECKS ARCHIVES OF SURGERY (2012)
Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients-a single-center cohort study
Soichiro Iimori et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial
Glenn M. Chertow et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study
Markus Ketteler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis
Glenn M. Chertow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Efficacy and Tolerability of Intravenous Paricalcitol in Calcitriol-Resistant Hemodialysis Patients with Secondary Hyperparathyroidism: 12-Month Prospective Study
Halil Zeki Tonbul et al.
RENAL FAILURE (2012)
Cinacalcet for the Treatment of Hyperparathyroidism in Kidney Transplant Recipients: A Systematic Review and Meta-analysis
Jordana B. Cohen et al.
TRANSPLANTATION (2012)
Cinacalcet Treatment for Stable Kidney Transplantation Patients With Hypercalcemia due to Persistent Secondary Hyperparathyroidism: A Long-term Follow-up
R. P. Paschoalin et al.
TRANSPLANTATION PROCEEDINGS (2012)
Current parathyroid hormone immunoassays do not adequately meet the needs of patients with chronic kidney disease
Alison Almond et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2012)
PTH Assays: Understanding What We Have and Forecasting What We Will Have
Jose Gilberto H. Vieira
JOURNAL OF OSTEOPOROSIS (2012)
Vegetarian Compared with Meat Dietary Protein Source and Phosphorus Homeostasis in Chronic Kidney Disease
Sharon M. Moe et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
Tamara Isakova et al.
KIDNEY INTERNATIONAL (2011)
Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5
Cesar Garcia-Canton et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis
Paolo Raggi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Vitamin D status and mortality in chronic kidney disease
Stefan Pilz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Comparison between Whole and Intact Parathyroid Hormone Assays
Masatomo Taniguchi et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2011)
KDOQI US Commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD)
Katrin Uhlig et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro
Yolanda Almaden et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
FGF23 Fails to Inhibit Uremic Parathyroid Glands
Rocio Canalejo et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease
H. Galitzer et al.
KIDNEY INTERNATIONAL (2010)
Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients
Tijana Krajisnik et al.
KIDNEY INTERNATIONAL (2010)
Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients
Hirotaka Komaba et al.
KIDNEY INTERNATIONAL (2010)
PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop
Vardit Lavi-Moshayoff et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Upregulation of parathyroid VDR expression by extracellular calcium is mediated by ERK1/2-MAPK signaling pathway
Sagrario Canadillas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Wnt signaling controls the fate of mesenchymal stem cells
Ling Ling et al.
GENE (2009)
Sevelamer Decreases Serum Uric Acid Concentration through Adsorption of Uric Acid in Maintenance Hemodialysis Patients
Iwao Ohno et al.
INTERNAL MEDICINE (2009)
25-Hydroxyvitamin D Levels, Race, and the Progression of Kidney Disease
Michal L. Melamed et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Fetuin-A Protects against Atherosclerotic Calcification in CKD
Ralf Westenfeld et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis
Pieter Evenepoel et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1
Jyothsna Gattineni et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
The calcimimetic AMG 641 accelerates regression of extraosseous calcification in uremic rats
Ignacio Lopez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
The OPTIMA study: Assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism
Piergiorgio Messa et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Short-term treatment with sevelamer increases serum fetuin-A concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients
Kayser Caglar et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD
Gerard M. London et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Cinacalcet Reduces the Set Point of the PTH-Calcium Curve
Casimiro Valle et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Intravenous alfacalcidol once weekly suppresses parathyroid hormone in hemodialysis patients
Nabieh Al-Hilali et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2008)
Lanthanum carbonate effectively controls serum phosphate without affecting serum calcium levels in patients undergoing hemodialysis
Takashi Shigematsu et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2008)
An LRP5-receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/β-catenin signaling
Peyman Bjorklund et al.
PLOS MEDICINE (2007)
Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: A pilot study
David M. Spiegel et al.
JOURNAL OF RENAL NUTRITION (2007)
Evaluation of cinacalcet therapy to lower cardiovascular events (EVOLVE): Rationale and design overview
Glenn M. Chertow et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Accumulation of nonphosphorylated β-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors
Peyman Bjorklund et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Inter-method variability in PTH measurement: Implication for the care of CKD patients
J-C Souberbielle et al.
KIDNEY INTERNATIONAL (2006)
Parathyroid hormone 7-84 induces hypocalcemia and inhibits the parathyroid hormone 1-84 secretory response to hypocalcemia in rats with intact parathyroid glands
Jinxing Huan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Long-term efficacy and tolerability of lanthanum carbonate: Results from a 3-year study
AJ Hutchison et al.
NEPHRON CLINICAL PRACTICE (2006)
Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry
G Lehmann et al.
KIDNEY INTERNATIONAL (2005)
Effects of serum from patients with chronic renal failure on rat hepatic cytochrome P450
J Michaud et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in Hemodialysis and peritoneal dialysis: A randomized, double-blind, multicenter study
JS Lindberg et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: A 6-month, randomized, comparative trial versus calcium carbonate
AJ Hutchison et al.
NEPHRON CLINICAL PRACTICE (2005)
Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis
GA Block et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
T Shimada et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
GA Block et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency
T Shigematsu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Determinants of progressive vascular calcification in haemodialysis patients
GM Chertow et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Proliferation in hyperplastic human and normal rat parathyroid glands:: Role of phosphate, calcitriol, and gender
Y Almaden et al.
KIDNEY INTERNATIONAL (2003)
Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism
SM Sprague et al.
KIDNEY INTERNATIONAL (2003)
Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers
T Larsson et al.
KIDNEY INTERNATIONAL (2003)
Regulation of parathyroid vitamin D receptor expression by extracellular calcium
B Garfia et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Human calcium-sensing receptor gene - Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D
L Canaff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
PTH 1-84 and PTH 7-84 in the noninvasive diagnosis of renal bone disease
G Coen et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
GM Chertow et al.
KIDNEY INTERNATIONAL (2002)
Aluminium and bone disease in chronic renal failure
HH Malluche
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Suppression of parathyroid hormone secretion in hemodialysis patients: Comparison of paricalcitol with calcitriol
SM Sprague et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor
CS Ritter et al.
KIDNEY INTERNATIONAL (2001)
Improved assessment of bone turnover by the PTH-(1-84) large C-PTH fragments ratio in ESRD patients
MC Monier-Faugere et al.
KIDNEY INTERNATIONAL (2001)
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
T Shimada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: Implications for improvement of accurate assessment of parathyroid function
P Gao et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Severely reduced production of Klotho in human chronic renal failure kidney
N Koh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Arterial stiffening and vascular calcifications in end-stage renal disease
AP Guérin et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2000)
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
WG Goodman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
